华法林过量用预防性维生素K输液成功治疗,没有严重的凝血病:一个病例报告
Ryosuke Omoto1, Yutaka Umemura1, Yuki Kokubu1
1Division of Trauma and Surgical Critical Care Osaka General Medical Center Osaka Japan.
Acute medicine & surgery
|January 10, 2025
概括
这项研究提出了一种对华法林过量管理的新方法. 预防性维生素K2注射成功地预防了大量华法林过量患者的严重并发症,这表明了潜在的新治疗策略.
科学领域:
- 药理学 药理学是指药理学的学科.
- 内部医学 内部医学
- 毒理学 毒理学 毒理学
背景情况:
- 华法林是一种用于血栓栓塞性疾病的常见抗凝剂.
- 缺乏对华法林过量服用的标准治疗方法.
- 存在高血时间与国际正常化比率 (INR) 管理指南,但过量服用方案尚未标准化.
研究的目的:
- 报告第一例华法林过量用预防性维生素K2治疗的病例.
- 为了评估预防性维生素K2在预防大量华法林过量后的并发症方面的疗效.
主要方法:
- 一名41岁的妇女以自杀意图摄入了230毫克华法林.
- 在INR升高之前,进行了预防性的连续menaquinone-4 (维生素K2) 注射.
- 患者监测包括INR水平和对凝血病和出血的评估.
主要成果:
- 尽管最初的华法林度很高,但预防性维生素K2预防了严重的凝血病和出血.
- 在72小时停止维生素K2后,INR升至1.8,但患者完全康复了.
- 这一案例证明了大量华法林过量剂量的成功管理,没有显著的不良事件.
结论:
- 在INR升高之前的预防性维生素K2注射可能是华法林过量治疗的有效策略.
- 这种方法可能为非依赖性患者的华法林过量治疗提供实用的治疗方法.
- 需要进一步的研究来确定维生素K2作为华法林过量治疗的标准治疗方法.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
607
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
607
Prevention of Further Absorption of Poison
779
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
779
One-Compartment Model: IV Infusion
150
Intravenous (IV) infusion is often utilized when continuous and controlled drug delivery is necessary, such as during surgery or in the treatment of chronic diseases. This method offers numerous advantages, including immediate drug action, precise control over dosage, and bypassing the first-pass metabolism.
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
150
Disorders of Hemostasis
696
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
696
Nonlinear Pharmacokinetics: Drug Elimination for IV Bolus Injection
38
In pharmacokinetics, the elimination rate of a drug following a capacity-limited model is primarily controlled by two parameters: Vmax and KM. These parameters are crucial in how the drug behaves inside the body after administration.
Following the administration of a single intravenous (IV) bolus injection, we can determine the concentration of the drug in the plasma at any given time. This calculation is achieved using a specific equation that integrates the values of Vmax and KM.
We can also...
Following the administration of a single intravenous (IV) bolus injection, we can determine the concentration of the drug in the plasma at any given time. This calculation is achieved using a specific equation that integrates the values of Vmax and KM.
We can also...
38


